[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631309":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":30,"centralContacts":38,"locations":45,"responsibleParty":57,"collaborators":30,"id":61,"slug":30,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":30,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":30,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":82,"overallStatus":87,"whyStopped":30,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1","EXPERIMENTAL","Perineural injection with 5% dextrose",[13],"Drug: Perineural injection with 5% dextrose (D5W).",{"label":15,"type":10,"description":16,"interventionNames":17},"Group 2","Local ozone injection",[18],"Drug: Local ozone injection",{"label":20,"type":10,"description":21,"interventionNames":22},"Group 3","Local glucocorticoid injection",[23],"Drug: Local glucocorticoid injection (dexamethasone).",[25,31,34],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","Perineural injection with 5% dextrose (D5W).","Group 1: Perineural injection with 5% dextrose (D5W).",[9],null,{"type":26,"name":16,"description":32,"armGroupLabels":33,"otherNames":30},"Group 2: Local ozone injection",[15],{"type":26,"name":35,"description":36,"armGroupLabels":37,"otherNames":30},"Local glucocorticoid injection (dexamethasone).","Group 3: Local glucocorticoid injection (dexamethasone).",[20],[39,44],{"name":40,"role":41,"phone":42,"phoneExt":30,"email":43},"Tasnim Ayad, Resident","CONTACT","+20 10 12537424","tasnimayad15@gmail.com",{"name":40,"role":41,"phone":30,"phoneExt":30,"email":30},[46],{"facility":5,"status":30,"city":47,"state":30,"zip":30,"country":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Tanta","Egypt",{"type":50,"coordinates":51},"Point",[52,53],31.00192,30.78847,{"lat":53,"lon":52},[56],{"name":40,"role":41,"phone":42,"phoneExt":30,"email":43},{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"PRINCIPAL_INVESTIGATOR","Tasnim Salah Mohamed Ayad","Resident","100631309",false,"NCT07498998","Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome","A Comparative Study Between Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome","Inclusion Criteria:\n\n* Adults aged 18-65 years with a clinical diagnosis of mild to moderate Carpal Tunnel Syndrome .\n* Clinical diagnosis of mild to moderate Carpal Tunnel Syndrome , as classified by Bland neurophysiological classification scale: Mild Carpal Tunnel Syndrome : Slow Distal Sensory Latency(≥3.6 ms), Normal Distal Motor Latency(\\\u003C 4.5 ms)\n* Moderate Carpal Tunnel Syndrome : Slow Distal Sensory Latency (≥ 3.6 ms), Slow Distal Motor Latency (4.5 - 6.4 ms)\n* Failure to respond to conservative treatments (e.g., splinting, activity modification, or oral medications) for at least 6 weeks.\n\nExclusion Criteria:\n\n* Patient refusal.\n* Severe Carpal Tunnel Syndrome requiring surgical intervention, as defined by the Bland neurophysiological classification scale: Severe Carpal Tunnel Syndrome: Absent Distal Sensory Latency and Slow Distal Motor Latency (4.5 - 6.4 ms)\n* Previous corticosteroid injection for Carpal Tunnel Syndrome within the last 6 months.\n* History of wrist trauma, surgery or anatomical abnormalities.\n* Systemic conditions such as diabetes mellitus, thyroid dysfunction or rheumatoid arthritis.\n* Pregnancy or lactation.\n* Contraindications to any of the study interventions (e.g., allergy to glucocorticoids or ozone).\n* Infection at wrist.","ALL","18 Years","65 Years",{"count":71,"type":72},105,"ESTIMATED","INTERVENTIONAL",[75],"NA","This study aims to compare the efficacy and outcomes of perineural injection with 5% dextrose, local ozone and glucocorticoid injection in the management of carpal tunnel syndrome.",[78,79,80,81],"Carpal Tunnel Syndrome (CTS)","Glucocorticoid","Pain","Dextrose",[83,84,85,86],"glucocorticoid","Ozone","5% dextrose","carpal tunnel syndrome","NOT_YET_RECRUITING","2026-03-24",{"date":90,"type":91},"2026-03-27","ACTUAL",{"date":93,"type":72},"2026-07-30",{"date":95,"type":72},"2026-08-30",{"name":5,"class":6},1]